Publication: Decreased Serum Adiponectin Reflects Low Vitamin D, High Interleukin 6, and Poor Physical Performance in Knee Osteoarthritis
Issued Date
2020-06-01
Resource Type
ISSN
16614917
0004069X
0004069X
Other identifier(s)
2-s2.0-85085342709
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Archivum Immunologiae et Therapiae Experimentalis. Vol.68, No.3 (2020)
Suggested Citation
Wanvisa Udomsinprasert, Pacharee Manoy, Pongsak Yuktanandana, Aree Tanavalee, Wilai Anomasiri, Sittisak Honsawek Decreased Serum Adiponectin Reflects Low Vitamin D, High Interleukin 6, and Poor Physical Performance in Knee Osteoarthritis. Archivum Immunologiae et Therapiae Experimentalis. Vol.68, No.3 (2020). doi:10.1007/s00005-020-00580-8 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/56201
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Decreased Serum Adiponectin Reflects Low Vitamin D, High Interleukin 6, and Poor Physical Performance in Knee Osteoarthritis
Other Contributor(s)
Abstract
© 2020, L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland. Obesity is a major contributor to deterioration of physical function toward sarcopenia in knee osteoarthritis (OA) due to its effect mediated through adipokines-derived molecules that have pro-/anti-inflammatory properties. This study aimed to investigate relationships of serum adiponectin, 25-hydroxyvitamin D (25(OH)D), interleukin (IL)-6, and physical performance in knee OA patients. A total of 175 knee OA patients and 52 healthy controls were recruited. Serum adiponectin, 25(OH)D, IL-6, biochemical markers, knee pain and functional scores, muscle strength, physical performance, metabolic parameters, and body composition were evaluated. Serum adiponectin levels were significantly higher in knee OA patients than that in controls, while its serum levels were significantly decreased in obese patients, especially those with sarcopenia. Furthermore, there were independent relationships of serum adiponectin with body composition parameters, knee pain scores, physical function tests, and metabolic parameters in knee OA patients. Besides, serum adiponectin levels were positively associated with 25(OH)D levels, and negatively correlated with C-reactive protein and IL-6 levels in knee OA. Additionally, low serum adiponectin could be used to distinguish knee OA patients with sarcopenic obesity from those without sarcopenic obesity. Circulating adiponectin levels may serve as a possible surrogate biomarker for exacerbated physical function in knee OA patients—particularly sarcopenic obesity.